Both in Biotechnology
CG Oncology vs CRISPR Therapeutics AG
Over the past year CGON returned +49.5% and CRSP returned −19.6%; their daily moves had a correlation of 0.27.
CGON +49.5% CRSP −19.6%Growth of $1, one year, split-adjusted
| Metric | CGON | CRSP |
|---|---|---|
| Price | $64.68 | $51.42 |
| Market cap | $5.73B | $4.97B |
| Today | +1.91% | −5.23% |
| 1 month | −5.4% | −7.3% |
| 6 months | −2.4% | −0.4% |
| Year to date | +55.8% | −1.9% |
| 1 year | +50.5% | −17.8% |
| Revenue growth (YoY) | — | +1041.4% |
| Gross margin | −239.2% | 100.0% |
| Net margin | −6832.8% | −895.3% |
| P/E (TTM) | — | — |
| Price / sales | 920.6× | 371.3× |
| Net cash | $1.03B | $1.78B |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 53.4% |
| Short % of float | 12.9% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).